Company Filing History:
Years Active: 2013-2014
Title: The Innovations of Andreas Spinrath
Introduction
Andreas Spinrath is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biological activity modulation, particularly concerning GPR17. With a total of 2 patents, his work has implications for various therapeutic applications.
Latest Patents
Spinrath's latest patents include innovative methods related to GPR17. The first patent, titled "GPR 17 agonists and screening assay," describes a method for determining a test compound's ability to modify the biological activity of GPR17. This method involves contacting the test compound with GPR17 or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I. The second patent, "Methods of identifying modulators of GPR17," similarly outlines a method for assessing the biological activity of GPR17 through the same contact process.
Career Highlights
Throughout his career, Spinrath has worked with esteemed institutions, including Rheinische Friedrich-Wilhelms-Universität Bonn. His research has focused on the modulation of biological pathways, contributing to advancements in pharmacology and therapeutic development.
Collaborations
Spinrath has collaborated with notable colleagues such as Evi Kostenis and Stephanie Hennen. Their joint efforts have furthered research in the field of GPR17 and its potential applications.
Conclusion
Andreas Spinrath's contributions to the field of biological activity modulation through his patents on GPR17 highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence research and development in therapeutic applications.